🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

183+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 183 recruiting trials for “hepatocellular-carcinoma

RecruitingNCT06955910

Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.

🏥 Istituto Oncologico Veneto IRCCS📍 1 site📅 Started Jun 2025View details ↗
Phase 4RecruitingNCT06903312

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

👨‍⚕️ Roberto Iacovelli, M.D.; Ph.D., Catholic University of Rome, Italy📍 1 site📅 Started Jun 2025View details ↗
Phase 1RecruitingNCT06198296

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

👨‍⚕️ Premal Lulla, MD, Baylor College of Medicine📍 1 site📅 Started Jun 2025View details ↗
Phase 1, PHASE2RecruitingNCT07053462

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

🏥 AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT06877637

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

👨‍⚕️ Karin Jirström, PhD, MD, professor, Region Skåne📍 3 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT06605664

Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab

🏥 Chang Gung Memorial Hospital📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06999174

Multiparametric MRI for Characterization of Hepatocellular Carcinoma

🏥 University Hospital Muenster📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT06915753

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

👨‍⚕️ Doug Warner, MD, Tyra Biosciences, Inc📍 16 sites📅 Started Apr 2025View details ↗
RecruitingNCT06916624

Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma

🏥 The Affiliated Hospital of Qingdao University📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06904183

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

👨‍⚕️ Kangshun Zhu, Dr., Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT07024680

Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC

👨‍⚕️ DingWei Ye, Postdoctoral, Fudan University📍 1 site📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06795022

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

🏥 AstraZeneca📍 20 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06708949

A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

👨‍⚕️ Eric Jonasch, MD, M.D. Anderson Cancer Center📍 5 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06551272

Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma

👨‍⚕️ Héloise BOURIEN, Dr, Centre de lutte contre le cancer Eugène Marquis📍 6 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT07246668

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

🏥 Yonsei University📍 1 site📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06741020

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

🏥 Zhejiang Cancer Hospital📍 2 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06376669

Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma

👨‍⚕️ Sherif Shaaban, MD, Johns Hopkins University📍 1 site📅 Started Feb 2025View details ↗
Phase 1RecruitingNCT06883539

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

🏥 LaunXP Biomedical Co., Ltd.📍 2 sites📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06432036

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

👨‍⚕️ Siddharth A Padia, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06537193

Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment

👨‍⚕️ So Yeon Kim, MD, PhD, Asan Medical Center📍 1 site📅 Started Dec 2024View details ↗
← PreviousPage 3 of 10Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →